GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sanara MedTech Inc (NAS:SMTI) » Definitions » Gross Profit

Sanara MedTech (Sanara MedTech) Gross Profit : $57.14 Mil (TTM As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Sanara MedTech Gross Profit?

Sanara MedTech's gross profit for the three months ended in Dec. 2023 was $15.90 Mil. Sanara MedTech's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was $57.14 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Sanara MedTech's gross profit for the three months ended in Dec. 2023 was $15.90 Mil. Sanara MedTech's Revenue for the three months ended in Dec. 2023 was $17.69 Mil. Therefore, Sanara MedTech's Gross Margin % for the quarter that ended in Dec. 2023 was 89.89%.

Sanara MedTech had a gross margin of 89.89% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Sanara MedTech was 91.30%. The lowest was 69.46%. And the median was 87.57%.


Sanara MedTech Gross Profit Historical Data

The historical data trend for Sanara MedTech's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanara MedTech Gross Profit Chart

Sanara MedTech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.56 13.97 21.83 39.48 57.14

Sanara MedTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.95 13.40 13.57 14.27 15.90

Competitive Comparison of Sanara MedTech's Gross Profit

For the Medical Instruments & Supplies subindustry, Sanara MedTech's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanara MedTech's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's Gross Profit distribution charts can be found below:

* The bar in red indicates where Sanara MedTech's Gross Profit falls into.



Sanara MedTech Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Sanara MedTech's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=64.99 - 7.853
=57.14

Sanara MedTech's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=17.69 - 1.788
=15.90

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $57.14 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Sanara MedTech's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=15.90 / 17.69
=89.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Sanara MedTech  (NAS:SMTI) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Sanara MedTech had a gross margin of 89.89% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Sanara MedTech Gross Profit Related Terms

Thank you for viewing the detailed overview of Sanara MedTech's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanara MedTech (Sanara MedTech) Business Description

Traded in Other Exchanges
N/A
Address
1200 Summit Avenue, Suite 414, Fort Worth, TX, USA, 76102
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser and BIAKOS Skin and Wound Gel.
Executives
Eric D Major director 751 MILLER DRIVE SE, LEESBURG VA 20175
Zachary B. Fleming officer: President - Surgical Div. 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Shawn M. Bowman officer: President - Wound Care Div. 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Rebecca E Mcmahon officer: President - R&D 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Sara N Ortwein director 5959 LAS COLINAS BOULEVARD, IRVING TX 75039-2298
Robert Andrew Desutter director 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Eric D Tanzberger director 1929 ALLEN PARKWAY, HOUSTON TX 77219
Christopher A. Morrison officer: President - Telehealth Svcs. 1200 SUMMIT AVENUE, SUITE 414, FORT WORTH TX 76102
Roszell Iii Mack director 1200 SUMMIT AVE, SUITE 414, FORT WORTH TX 76102
Cgi Cellerate Rx, Llc 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Catalyst Rochal, Llc 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
Bradley J. Gurasich 10 percent owner C/O THE CATALYST GROUP, INC., 7500 RIALTO BLVD., BLDG. II, SUITE 220, AUSTIN TX 78735
J Michael Carmena director, officer: Principal Executive Officer 1200 SUMMIT AVE STE 414, FORT WORTH TX 76102
Michael D. Mcneil officer: Chief Financial Officer 1200 SUMMIT AVE, STE 414, FORT WORTH TX 76102
Catalyst Group, Inc. 10 percent owner 1375 ENCLAVE PARKWAY, HOUSTON TX 77077

Sanara MedTech (Sanara MedTech) Headlines

From GuruFocus

Sanara MedTech Inc. Announces First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 06-15-2022

Sanara MedTech and InfuSystem Announce Wound Therapy Partnership

By Value_Insider Value_Insider 11-03-2022

Sanara MedTech to Participate in Two Upcoming Healthcare Conferences

By Value_Insider Value_Insider 11-21-2022

InfuSystem and Sanara MedTech Announce Wound Therapy Partnership

By Business Wire Business Wire 11-03-2022

Sanara MedTech Inc. Announces First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 07-05-2022

Sanara MedTech Inc. Announces First Quarter 2022 Results

By GuruFocusNews GuruFocusNews 05-26-2022

Sanara MedTech Inc. Announces First Quarter 2022 Results

By PurpleRose PurpleRose 07-15-2022